Raphael Mechoulam
Raphael Mechoulam
Professor of Medicinal Chemistry, Hebrew University
Email verificata su cc.huji.ac.il - Home page
Citata da
Citata da
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
WA Devane, L Hanus, A Breuer, RG Pertwee, LA Stevenson, G Griffin, ...
Science 258 (5090), 1946-1949, 1992
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, NE Kaminski, ...
Biochemical pharmacology 50 (1), 83-90, 1995
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett, F Barth, TI Bonner, G Cabral, P Casellas, WA Devane, ...
Pharmacological reviews 54 (2), 161-202, 2002
Isolation, structure, and partial synthesis of an active constituent of hashish
Y Gaoni, R Mechoulam
Journal of the American chemical society 86 (8), 1646-1647, 1964
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2
RG Pertwee, AC Howlett, ME Abood, SPH Alexander, V Di Marzo, ...
Pharmacological reviews 62 (4), 588-631, 2010
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanuš, S Abu-Lafi, E Fride, A Breuer, Z Vogel, DE Shalev, I Kustanovich, ...
Proceedings of the National Academy of Sciences 98 (7), 3662-3665, 2001
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno, L Hanuš, L De Petrocellis, S Tchilibon, DE Ponde, I Brandi, ...
British journal of pharmacology 134 (4), 845-852, 2001
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
D Panikashvili, C Simeonidou, S Ben-Shabat, L Hanuš, A Breuer, ...
Nature 413 (6855), 527-531, 2001
The endocannabinoid system and the brain
R Mechoulam, LA Parker
Annual review of psychology 64, 21-47, 2013
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
AA Izzo, F Borrelli, R Capasso, V Di Marzo, R Mechoulam
Trends in pharmacological sciences 30 (10), 515-527, 2009
Marihuana chemistry
R Mechoulam
Science 168 (3936), 1159-1166, 1970
HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor
L Hanuš, A Breuer, S Tchilibon, S Shiloah, D Goldenberg, M Horowitz, ...
Proceedings of the National Academy of Sciences 96 (25), 14228-14233, 1999
Chronic administration of cannabidiol to healthy volunteers and epileptic patients
JM Cunha, EA Carlini, AE Pereira, OL Ramos, C Pimentel, R Gagliardi, ...
Pharmacology 21 (3), 175-185, 1980
A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1
R Mechoulam, Y Gaoni
Journal of the American Chemical Society 87 (14), 3273-3275, 1965
R Mechoulam, E Fride, V Di Marzo
European journal of pharmacology 359 (1), 1-18, 1998
An easier, reproducible, and mass‐production method to study the blood–brain barrier in vitro
MP Dehouck, S Mresse, P Delorme, JC Fruchart, R Cecchelli
Journal of neurochemistry 54 (5), 1798-1801, 1990
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
E Fride, R Mechoulam
European journal of pharmacology 231 (2), 313-314, 1993
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
AM Malfait, R Gallily, PF Sumariwalla, AS Malik, E Andreakos, ...
Proceedings of the National Academy of Sciences 97 (17), 9561-9566, 2000
The cannabinoid receptors
AC Howlett
Prostaglandins & other lipid mediators 68, 619-631, 2002
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
S Ben-Shabat, E Fride, T Sheskin, T Tamiri, MH Rhee, Z Vogel, T Bisogno, ...
European journal of pharmacology 353 (1), 23-31, 1998
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20